American Association for the Advancement of Science, Science Translational Medicine, 549(12), 2020
DOI: 10.1126/scitranslmed.aaz6992
Full text: Unavailable
Improved understanding of the resistance of bacterial pathogens to antibiotics is fueling fresh approaches to identify new compounds, bacterial targets, and drug regimens.